BioSpace News Archive

This FDA EUA first and only PCR quality, single-use, COVID-19 at home, self-test kit is available for $55 to all Amazon US customers

ProMIS Neurosciences, Inc. ;, a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company’s scientific advisory board.

RECONNECT, a confirmatory pivotal trial of Zygel™ in patients with FXS, expected to be initiated in the third quarter of 2021

Juno Diagnostics, a company focused on improving access to vital genetic health information and led by industry experts, announced the closing of an expanded Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund.

Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Conference 12 May 2021

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the U.S. Food and Drug Administration has granted Fast Track designation to losmapimod for the potential treatment of facioscapulohumeral muscular dystrophy.

Leading experts in the field will advise on clinical development of PureTech’s lead, wholly-owned product candidate, LYT-100, in idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases

Labcorp announced that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches.

Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, announces further expansion of its intellectual property portfolio with its first-ever patent granted in India.

Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter injury (WMI) and myelin repair in premature babies, today announced a seed investment from Xontogeny, LLC to advance their lead program through IND-enabling work.